Cooper Companies AAQS 2024

Cooper Companies AAQS

7

Cooper Companies Dividenditootlus

0,07 %

Ticker

COO

ISIN

US2166484020

WKN

867409

Cooper Companies omab hetkel AAQS väärtuseks 7. Kõrget AAQS-i võib pidada positiivseks märgiks, et ettevõte areneb edukalt. Investorid võivad eeldada, et ettevõte on heas seisus kasumi teenimiseks. Teisest küljest on oluline vaadelda Cooper Companies aktsia AAQS-i võrdluses saadud kasumite ja sama sektori teiste ettevõtetega. Kõrge AAQS ei ole absoluutne garantii positiivseks tulevikuks. Ainult nii on võimalik saada täielik ülevaade ettevõtte sooritusest. Ettevõtte arengu paremaks hindamiseks on oluline võrrelda AAQS-i sama sektori teiste ettevõtetega. Üldiselt peaksid investorid alati vaatlema ettevõtte AAQS-i seoses teiste näitajatega nagu kasum, EBIT, rahavoog ja muud, et teha põhjendatud investeerimisotsus.

Cooper Companies Aktienanalyse

Mis teeb Cooper Companies?

Cooper Companies Inc is a leading company in the medical technology industry and was founded in 1958. The company is headquartered in San Ramon, California, USA, and employs more than 12,000 employees worldwide. Over the past six decades, Cooper Companies Inc has expanded its business activities in various areas of ophthalmology and is now one of the world's leading providers of innovative technologies and products that contribute to improving vision. Business model: The company's business model is focused on developing, manufacturing, and distributing top-quality medical devices and products tailored to the needs of customers. The company has divided its business activities into two different business segments that cater to the needs of customers. The first business segment is CooperVision, which focuses on contact lenses. CooperVision offers a wide range of contact lenses and accessories tailored to the specific needs of patients. The business segment includes contact lenses for nearsightedness, farsightedness, astigmatism, and presbyopia. Through its research and development, CooperVision has been able to develop groundbreaking technologies that make wearing contact lenses more comfortable and safer. The second business segment is CooperSurgical, which focuses on medical devices and instruments used in the gynecology and obstetrics department. CooperSurgical offers a wide range of medical devices and products, including fertility products, surgical instruments, and diagnostic devices. Products: Cooper Companies Inc offers a wide range of products tailored to the needs of its customers. In the field of contact lenses, CooperVision offers a wide range of products tailored to the specific needs of patients. Here are some of the most popular models: Biofinity contact lenses: These contact lenses are designed for excellent comfort and are ideal for people with dry eyes. They are made of a highly oxygen-permeable material that helps reduce dry eye syndrome in contact lens wearers. MyDay contact lenses: According to CooperVision, MyDay contact lenses are softer, lighter, and more comfortable than other contact lenses. They are made of an innovative material called Aquaform, which leads to a soft, moist, and breathable lens material. Clariti contact lenses: These silicone hydrogel contact lenses are designed to keep vision sharp and clear while keeping the eye comfortable. They are ideal for people with dry eyes and provide UV protection to protect the eyes from harmful sun rays. In the field of medical technology, CooperSurgical offers various products, including: Endometrial instrument: CooperSurgical's endometrial device is a diagnostic instrument used to examine the uterus. It consists of a specially designed camera system that provides razor-sharp images. Vacu-Lok curette system: This surgical instrument by CooperSurgical is designed to take tissue samples from the uterine wall. It consists of a modern suction system that quickly and effectively retrieves the samples. ElaStop clips: These surgical clips by CooperSurgical are used to stop bleeding during gynecological surgical procedures. They are made of a flexible yet durable material that allows excellent control of bleeding. Summary: Overall, Cooper Companies Inc is a pioneer in the medical technology industry and a global leader in contact lenses and medical devices in the field of ophthalmology and gynecology. With its innovative research and development and a strong focus on customized products, Cooper Companies Inc has been able to improve the vision of millions of people worldwide. The company is well positioned to continue to be successful in the future and present the world with innovative technologies. Cooper Companies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Sagedased küsimused Cooper Companies aktsia kohta

Aktsiasäästuplaanid pakuvad investoritele atraktiivset võimalust pikema aja jooksul vara koguda. Üheks peamiseks eeliseks on nn keskmise maksumuse efekt: investeerides regulaarselt kindla summa aktsiatesse või aktsiafondidesse, ostetakse automaatselt rohkem osakuid siis, kui hinnad on madalad, ja vähem, kui need on kõrged. See võib aja jooksul viia soodsama keskmise hinna per osakuni. Lisaks võimaldavad aktsiasäästuplaanid ka väikeinvestoritel pääseda ligi kallimatele aktsiatele, kuna nendega saab liituda juba väikeste summadega. Regulaarne investeerimine soodustab ka distsiplineeritud investeerimisstrateegiat ja aitab vältida emotsionaalsete otsuste, nagu impulsiivne ostmine või müümine. Peale selle saavad investorid osa aktsiate võimalikust väärtuse kasvust ning dividendide väljamaksetest, mida saab reinvesteerida, mis tugevdab intressiintressi efekti ning seeläbi investeeritud kapitali kasvu.

Cooper Companies aktsia on järgmiste pakkujate juures säästuplaaniga seotav: Trade Republic

Andere Kennzahlen von Cooper Companies

Meie Cooper Companies Käive-aktsia analüüs sisaldab olulisi finantsnäitajaid, nagu käive, kasum, P/E suhe, P/S suhe, EBIT, samuti teavet dividendi kohta. Lisaks käsitleme aspekte nagu aktsiad, turukapitalisatsioon, võlad, omakapital ja kohustused ettevõttes Cooper Companies Käive. Kui otsite nende teemade kohta põhjalikumat teavet, pakume teile meie alamlehtedel üksikasjalikke analüüse: